Nat Rev Cancer. 2006 Aug;6(8):613-25.

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

Source

Lankenau Institute for Medical Research, Wynnewood, Pennsylvania 19096, USA. MullerA@MLHS.ORG

Erratum in

Nat Rev Cancer. 2006 Sep;6(9):742.

Abstract

Cancer immunotherapy has been predominantly focused on biologically based intervention strategies. However, recent advances in the understanding of tumour-host interactions at the molecular level have revealed targets that might be amenable to intervention with small-molecule inhibitors. In particular, key effectors of tumoral immune escape have been identified that contribute to a dominant toleragenic state that is suspected of limiting the successful implementation of treatment strategies that rely on boosting immune function. Within the context of the pathophysiology of cancer-associated immune tolerance, this Review delineates potential molecular targets for therapeutic intervention and the progress that has been made in developing small-molecule inhibitors.

PMID:: 16862192; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. [Expert Opin Ther Targets. 2005]
Review Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.
Muller AJ, Malachowski WP, Prendergast GC. Expert Opin Ther Targets. 2005 Aug; 9(4):831-49.
Review Marrying immunotherapy with chemotherapy: why say IDO? [Cancer Res. 2005]
Review Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ, Prendergast GC. Cancer Res. 2005 Sep 15; 65(18):8065-8.
Review Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. [Immunol Rev. 2008]
Review Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
Katz JB, Muller AJ, Prendergast GC. Immunol Rev. 2008 Apr; 222:206-21.
Review Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development. [Endocr Metab Immune Disord Dru...]
Review Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development.
Rutella S, Bonanno G, De Cristofaro R. Endocr Metab Immune Disord Drug Targets. 2009 Jun; 9(2):151-77.
Review Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction? [Langenbecks Arch Surg. 2008]
Review Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?
Löb S, Königsrainer A. Langenbecks Arch Surg. 2008 Nov; 393(6):995-1003. Epub 2007 Dec 4.

See reviews... See all...

Cited by 18 PubMed Central articles

Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases. [Front Immunol. 2012]
Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.
Li L, Huang L, Lemos HP, Mautino M, Mellor AL. Front Immunol. 2012; 3:109. Epub 2012 May 11.
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion. [Cancer Immunol Immunother. 2010]
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.
Muller AJ, DuHadaway JB, Chang MY, Ramalingam A, Sutanto-Ward E, Boulden J, Soler AP, Mandik-Nayak L, Gilmour SK, Prendergast GC. Cancer Immunol Immunother. 2010 Nov; 59(11):1655-63. Epub 2010 Jul 17.
Review Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway. [Am J Pathol. 2010]
Review Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway.
Prendergast GC, Metz R, Muller AJ. Am J Pathol. 2010 May; 176(5):2082-7. Epub 2010 Mar 12.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibit...
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.
Nat Rev Cancer. 2006 Aug ;6(8):613-25.

PubMed
Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappa...
Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Oncogene. 2007 Feb 1 ;26(5):673-82. Epub 2006 Jul 24 .

PubMed
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease.
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease.
Nature. 2006 Aug 17 ;442(7104):831-5. Epub 2006 Jul 23 .

PubMed
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia l...
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.
Nature. 2006 Aug 24 ;442(7105):920-4. Epub 2006 Jul 16 .

PubMed
Sedation and histamine H1-receptor antagonism: studies in man with the enantiome...
Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.
Br J Pharmacol. 1991 Sep ;104(1):270-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

Source

Erratum in

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 18 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information